HOME >> BIOLOGY >> NEWS
Dose of PTEN protein found to determine progression of prostate cancer

NEW YORK, NY October 27 - In patients with prostate cancer, one change that can be seen at the molecular level is the loss of the PTEN tumor suppressor gene, a gene responsible for restricting cell proliferation. One or both copies of the PTEN gene are found to have been lost in 70 percent of prostate cancer patients at the time of diagnosis. It has generally been believed that one remaining copy would still protect against tumor progression to advanced metastatic cancer.

But now, for the first time, scientists at Memorial Sloan-Kettering Cancer Center have established mouse models for prostate cancer that have varying "doses" or amounts of Pten protein produced from the remaining gene. Their results show that the activity of the single Pten gene does not necessarily protect against prostate cancer. Instead, the dose determines whether the tumor will become either an aggressive cancer or take a slow path towards microscopic features of growth, but remain benign. This new understanding of the natural history of the disease could allow researchers to develop novel clinical strategies to diagnose, treat, and possibly prevent prostate cancer. This article will appear both as HTML and in print in the December 23, 2003 issue of the new, open access journal published by the Public Library of Science. It appears in PDF form online as a pre-issue publication on October 27, 2003 at www.plosbiology.org.

"We have shown that prostate cancer development is not just affected by mutation and loss of the PTEN gene but that its progression is dose-dependent on the PTEN protein, which we have measured for the first time," said Pier Paolo Pandolfi, M.D., Ph.D., Head of the Molecular and Developmental Biology Laboratory at Memorial Sloan-Kettering and the study's senior author. "Two men, each with one PTEN gene left, could have totally different disease outcomes depending on the actual dose of PTEN protein coming from that ge
'"/>

Contact: Joanne Nicholas
mediastaff@mskcc.org
212-639-3573
Memorial Sloan-Kettering Cancer Center
27-Oct-2003


Page: 1 2 3

Related biology news :

1. New molecular link key to cellular proteins involved in cancer progression, other diseases
2. Researchers identify protein promoting vascular tumor growth
3. UCI scientists successfully target key HIV protein; breakthrough may lead to new drug therapies
4. Experimental drug shown to block mutant protein causing blood disease
5. Loss of the neuronal adhesion protein d-catenin leads to severe cognitive dysfunction
6. Images of tail of protein needed for cell multiplication suggest anticancer drug targets
7. New dye directly reveals activated proteins in living cells
8. Disruption of protein-folding causes neurodegeneration, mental retardation
9. A new protein is discovered to play a key role in cancer progression
10. Optimizing proteins death domain halts leukemia in laboratory study
11. Stuck on you: Scientists lay bare secrets of bacterial attachment proteins

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/18/2018)... CAMBRIDGE, Mass. (PRWEB) , ... October 18, 2018 ... ... provider to the Boston/Cambridge biotech industry, announces the grand opening of its new ... single story building, featuring 14 rental suites, a wet lab, tissue culture, necropsy ...
(Date:10/17/2018)... ... October 17, 2018 , ... ... sciences, diagnostics, and scientific healthcare companies, proudly announces Insights: Scientific Healthcare Investing ... San Francisco. In conjunction with co-producer Biocom, the association representing the life ...
(Date:10/16/2018)... ... 2018 , ... Nanomedical Diagnostics , leading manufacturer of ... “ Graphene-based Biosensor for On-Chip Detection of Bio-Orthogonally Labeled Proteins ” in the ... portable digital device for biosensing… that can be employed for any click-able application.” ...
Breaking Biology News(10 mins):
(Date:10/5/2018)... ... October 04, 2018 , ... Earthres Group, Inc., a multi-disciplinary ... company’s brand identity and better reflects its current breadth of markets and services. ... expertise and related support services to clients in seven market sectors, and currently ...
(Date:10/2/2018)... ... October 02, 2018 , ... Finalists for the 2018 ... AssurEOR product line was chosen for its advancements in the production chemicals category. ... innovations in upstream oil applications that are positively impacting the industry. The winners ...
(Date:9/29/2018)... ... September 29, 2018 , ... Voxx ... early-stage companies to access the power of influence analytics and data-driven engagement decision ... a broader market that didn’t necessarily have access to the same financial resources ...
(Date:9/27/2018)... , ... September 26, 2018 , ... ... Dr. B. Melina Cimler, a senior quality, regulatory, and in vitro diagnostic device ... FDA-regulated global diagnostic industry has joined the firm as an Expert Consultant. Her ...
Breaking Biology Technology:
Cached News: